Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The history page now displays Revision: v3.5.4, replacing the former v3.5.3 and signaling a new UI/software revision for the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:16:00.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History. The previous revision v3.5.2 was removed from the list to reflect the latest changes to the study record.
    Difference
    0.1%
    Check dated 2026-04-30T17:48:41.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Version 44 adds Contacts/Locations, Study Design, and Study Status and updates the revision to v3.5.2; the previous revision v3.5.0 was removed on 2025-11-13.
    Difference
    0.4%
    Check dated 2026-04-16T10:28:40.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows the latest revision as v3.5.0, replacing the previous v3.4.3. This updates the revision indicator without altering study data.
    Difference
    0.1%
    Check dated 2026-03-25T19:36:54.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:11:52.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The history shows an added Revision: v3.4.2 and deletions of a funding notice and Revision: v3.4.1; these are administrative site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:29:30.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.